Veeva Systems Acquires Copli, Unveils Falcon MLR Platform
Veeva Systems expands its life sciences cloud with the Copli acquisition and a new AI-driven medical-legal-regulatory review tool.
Veeva Systems has acquired Copli and simultaneously launched Veeva Falcon MLR, a new medical-legal-regulatory review platform aimed at accelerating compliance workflows for life sciences companies. The dual move signals an aggressive push by the cloud software giant to deepen its hold on the highly regulated pharmaceutical and biotech market.
The Copli acquisition brings additional technology and talent into Veeva's ecosystem, positioning the company to strengthen its content and review capabilities at a time when drug manufacturers face mounting pressure to speed up go-to-market timelines without sacrificing regulatory compliance.
Read more Nordson's Prodigy HDLV System Targets Precision Powder Coating →
Veeva Falcon MLR is designed to modernize the often slow and costly MLR review process that governs how life sciences firms approve promotional and medical content before it reaches healthcare professionals or consumers. By embedding this capability directly into Veeva's broader platform, the company aims to reduce the friction that has historically made compliance a bottleneck for commercial teams.
The announcement reflects a broader industry trend in which enterprise software providers are racing to embed automation and AI-adjacent tools into compliance-heavy verticals, where even modest efficiency gains translate into significant cost savings and faster product launches. Veeva, which has long positioned itself as the dominant cloud vendor for life sciences, appears to be reinforcing that moat with targeted acquisitions and organic product development.
Continue reading at Yahoo Finance.
